Australia markets closed

Adaptive Biotechnologies Corporation (1HM.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
42.24+3.16 (+8.10%)
At close: 03:30PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
174,502
170,276
185,308
154,344
98,382
Cost of revenue
74,923
75,553
57,909
49,301
22,530
Gross profit
99,579
94,723
127,399
105,043
75,852
Operating expenses
Research development
119,761
122,117
141,756
142,343
116,072
Selling general and administrative
171,290
172,513
184,130
169,967
110,894
Total operating expenses
292,754
296,329
327,585
314,009
228,669
Operating income or loss
-193,175
-201,606
-200,186
-208,966
-152,817
Interest expense
13,262
13,800
4,238
0
-
Total other income/expenses net
-
-25,429
-
-
-
Income before tax
-215,137
-225,304
-200,368
-207,298
-146,227
Income from continuing operations
-215,137
-225,304
-200,368
-207,298
-146,227
Net income
-215,058
-225,250
-200,191
-207,279
-146,227
Net income available to common shareholders
-215,058
-225,250
-200,191
-207,279
-146,227
Basic EPS
-1.36
-
-1.40
-1.48
-1.11
Diluted EPS
-1.36
-
-1.40
-1.48
-1.11
Basic average shares
143,922
-
142,516
140,355
131,216
Diluted average shares
143,922
-
142,516
140,355
131,216